THEXYA
Live / Registered — Registered (as of 20 Jul 2021)
What this means for you
Registered since 20 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90192552
- Registration number
- 6423932
- Mark type
- Stylized text
- Filed
- 18 Sept 2020
- Published for opposition
- 16 Mar 2021
- Registered
- 20 Jul 2021
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Hunter's syndrome
Owner
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
Prosecution history
- 20 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 16 Jun 2021 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 16 Jun 2021 — NOTICE OF ALLOWANCE CANCELLED
- 16 Jun 2021 — PETITION TO DIRECTOR DISMISSED
- 15 Jun 2021 — ASSIGNED TO PETITION STAFF
- 11 May 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 May 2021 — TEAS PETITION TO AMEND BASIS RECEIVED
- 16 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Mar 2021 — PUBLISHED FOR OPPOSITION
- 24 Feb 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Feb 2021 — ELECTRONIC RECORD REVIEW COMPLETE
- 05 Feb 2021 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 02 Feb 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Feb 2021 — ASSIGNED TO EXAMINER
- 28 Oct 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED